Research Paper Volume 13, Issue 2 pp 2780—2802

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

Identification of the 10-IRG risk model in the training set. (A, B) Risk score distribution and survival status of low-risk (green) (n=101) and high risk (red) UBC cases (n=101) in the training group. (C) Survival analysis of the high-risk UBC (n=101) and low-risk UBC (n=101) cases. (D) Time-dependent ROC curve analysis showing the 3-year (red) and 5-year (blue) survival of the 10 IRGs expression patterns. (E) Heat map showing expression level of risk genes in the high and low-risk BLCA patients in the training set.

Figure 3. Identification of the 10-IRG risk model in the training set. (A, B) Risk score distribution and survival status of low-risk (green) (n=101) and high risk (red) UBC cases (n=101) in the training group. (C) Survival analysis of the high-risk UBC (n=101) and low-risk UBC (n=101) cases. (D) Time-dependent ROC curve analysis showing the 3-year (red) and 5-year (blue) survival of the 10 IRGs expression patterns. (E) Heat map showing expression level of risk genes in the high and low-risk BLCA patients in the training set.